cas 64700-65-8|| where to buy Methyl (R)-2-pyrrolidone-5-carboxylate

Product Name:Methyl (R)-2-pyrrolidone-5-carboxylate

IUPAC Name:methyl (2R)-5-oxopyrrolidine-2-carboxylate

Packing Unit	Available Stock	Price($)
CM119854-25g	in stock	ƦƦ
CM119854-100g	in stock	ũưȺ
CM119854-500g	in stock	ǶũǜȺ

For R&D use only.

Inquiry Form

Chemical Name

CAS Number

Quantity*

Required Specifications*
(Assay %, Material Grade etc.)

Contact Name*

Contact Email*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 64700-65-8 regularly via the above email.

Additional Notes

Verification code*

refresh

: CAS NO:64700-65-8; Molecular Formula:C6H9NO3; Melting Point:-; Smiles Code:O=C1N[C@@H](C(OC)=O)CC1; Density:

: Catalog Number:CM119854; Molecular Weight:143.14; Boiling Point:; MDL No:MFCD01318621; Storage:Keep in a tight container and store at ambient temperature

: Amino Acids and Peptides; Amino acids are organic compounds containing a basic amino group and an acidic carboxyl group. Because amino acids contain both amino and carboxyl groups, they can be polymerized in an end-to-end manner, removing a molecule of water to form a covalent amide bond or peptide bond. Many amino acids are linked together end to end to form a polypeptide. Amino acids and peptides are important components in the fields of medicine and life sciences.; amino acids wholesale; if you are finding amino acids wholesaler in china, we will be your best choose! We have our own factory, so we can give you a cheap price!

: Pyrrolidines; Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.

: HRS-4642; HRS-4642 is a high affinity, selective, long-acting, and non-covalent KRAS G12D inhibitor, with an affinity constant of 0.083 nM. HRS-4642 demonstrated robust efficacy against KRAS G12D-mutant cancers both in vitro and in vivo. Importantly, in a phase 1 clinical trial, HRS-4642 exhibited promising anti-tumor activity in the escalating dosing cohorts. Furthermore, the sensitization and resistance spectrum for HRS-4642 was deciphered through genome-wide CRISPR-Cas9 screening, which unveiled proteasome as a sensitization target. HRS-4642, either as a single agent or in combination with carfilzomib, reshaped the tumor microenvironment toward an immune-permissive one.